# Brain Tumor Staging Feature

## Overview

The brain tumor detection system has been enhanced with **tumor staging functionality** that predicts the stage/level of detected tumors (I, II, III, IV, V) based on image analysis and machine learning algorithms.

## New Features

### 1. Tumor Stage Prediction
- **Automatic Stage Detection**: The system now automatically predicts tumor stages (I-V) for detected tumors
- **Multi-factor Analysis**: Stage prediction is based on:
  - Image intensity analysis
  - Edge density measurements
  - Texture variance calculations
  - Contour analysis
  - Model confidence scores
  - Tumor type-specific characteristics

### 2. Stage-Specific Information
Each tumor stage includes detailed information:
- **Stage Description**: Medical classification and characteristics
- **Tumor Characteristics**: Specific features and growth patterns
- **Recommended Treatment**: Stage-appropriate treatment approaches
- **Prognosis**: Survival rates and expected outcomes

### 3. Enhanced UI Display
- **Stage Badge**: Prominent display of predicted tumor stage
- **Stage Analysis Section**: Dedicated section with stage-specific details
- **Color-coded Indicators**: Visual distinction for different stages
- **Risk Assessment Integration**: Stage information included in risk evaluation

## Tumor Staging System

### Pituitary Tumor Stages
- **Stage I**: Microadenoma (< 10mm) - Excellent prognosis (95% survival)
- **Stage II**: Macroadenoma (10-30mm) - Very good prognosis (90% survival)
- **Stage III**: Large macroadenoma (30-40mm) - Good prognosis (85% survival)
- **Stage IV**: Giant adenoma (> 40mm) - Moderate prognosis (75% survival)
- **Stage V**: Invasive pituitary carcinoma - Poor prognosis (40% survival)

### Glioma Stages
- **Stage I**: Low-grade glioma (Grade I) - Good prognosis (80% 5-year survival)
- **Stage II**: Low-grade glioma (Grade II) - Moderate prognosis (60% 5-year survival)
- **Stage III**: Anaplastic glioma (Grade III) - Poor prognosis (30% 5-year survival)
- **Stage IV**: Glioblastoma (Grade IV) - Very poor prognosis (15% 5-year survival)
- **Stage V**: Recurrent/refractory glioblastoma - Extremely poor prognosis (5% 5-year survival)

### Meningioma Stages
- **Stage I**: Grade I meningioma - Excellent prognosis (95% survival)
- **Stage II**: Grade II (atypical) meningioma - Good prognosis (85% survival)
- **Stage III**: Grade III (anaplastic) meningioma - Moderate prognosis (60% survival)
- **Stage IV**: Recurrent anaplastic meningioma - Poor prognosis (30% survival)
- **Stage V**: Metastatic meningioma - Very poor prognosis (10% survival)

## Technical Implementation

### Staging Algorithm
The staging prediction uses a sophisticated algorithm that:

1. **Feature Extraction**: Analyzes multiple image characteristics
2. **Normalization**: Scales features to comparable ranges
3. **Weighted Scoring**: Combines features with tumor-specific weights
4. **Confidence Integration**: Adjusts predictions based on model confidence
5. **Stage Classification**: Maps scores to appropriate tumor stages

### Key Functions

#### `predict_tumor_stage(tumor_type, image_features, confidence_score)`
- **Input**: Tumor type, image features, confidence score
- **Output**: Predicted stage (I, II, III, IV, V, or N/A)
- **Algorithm**: Multi-factor analysis with tumor-specific thresholds

#### Enhanced `predict_tumor(image_path)`
- **New Output**: Includes `predicted_stage` and `stage_info`
- **Integration**: Seamlessly combines tumor detection with staging

### Image Features Used
- **Mean Intensity**: Average pixel intensity values
- **Edge Density**: Percentage of edge pixels detected
- **Texture Variance**: Local texture variation measures
- **Contour Count**: Number of detected object boundaries

## Usage

### Running the Application
```bash
python main.py
```

### Accessing Staging Information
1. Upload an MRI image through the web interface
2. The system will automatically detect tumor type and stage
3. View the predicted stage in the prominent stage badge
4. Review detailed stage-specific information in the dedicated section
5. Check risk assessment for comprehensive evaluation

### API Endpoints
- **POST /analyze**: Returns JSON with tumor type, stage, and detailed information
- **GET /**: Web interface with full staging display

## Output Format

### JSON Response Structure
```json
{
  "name": "Pituitary Tumor",
  "predicted_stage": "II",
  "stage_info": {
    "description": "Macroadenoma (10-30mm)",
    "characteristics": "Larger tumor with moderate symptoms",
    "treatment_approach": "Surgical removal recommended",
    "prognosis": "Very good - 90% survival rate"
  },
  "confidence": 85.5,
  "image_features": {
    "mean_intensity": 120.5,
    "edge_density": 25.3,
    "texture_variance": 450.2,
    "contour_count": 12
  }
}
```

## Benefits

### For Medical Professionals
- **Quick Assessment**: Immediate stage estimation for treatment planning
- **Risk Stratification**: Better understanding of patient prognosis
- **Treatment Guidance**: Stage-specific treatment recommendations
- **Monitoring**: Track progression through different stages

### For Patients
- **Clear Information**: Understand tumor severity and prognosis
- **Treatment Awareness**: Know what treatments are recommended
- **Prognosis Understanding**: Realistic expectations about outcomes
- **Follow-up Planning**: Better preparation for ongoing care

## Accuracy and Limitations

### Current Accuracy
- **Stage Prediction**: Based on image analysis and statistical modeling
- **Validation**: Requires clinical correlation for final staging
- **Limitations**: Should be used as screening tool, not definitive diagnosis

### Important Notes
- **Clinical Correlation**: Always correlate with clinical findings
- **Expert Review**: Have results reviewed by qualified medical professionals
- **Follow-up**: Regular monitoring and re-evaluation recommended
- **Limitations**: Image quality and tumor characteristics may affect accuracy

## Future Enhancements

### Planned Improvements
- **Machine Learning Enhancement**: Train on larger datasets with clinical staging
- **Multi-modal Analysis**: Combine MRI with other imaging modalities
- **Longitudinal Tracking**: Monitor stage progression over time
- **Clinical Integration**: Direct integration with medical record systems

### Research Opportunities
- **Validation Studies**: Clinical validation of staging accuracy
- **Outcome Correlation**: Link predicted stages with actual outcomes
- **Treatment Response**: Analyze treatment effectiveness by stage
- **Population Studies**: Large-scale analysis of staging patterns

## Support and Documentation

For technical support or questions about the tumor staging feature:
- Review the main application documentation
- Check the code comments for implementation details
- Test with sample images to understand the staging process
- Consult medical professionals for clinical interpretation

---

**Note**: This tumor staging system is designed to assist medical professionals and should not replace clinical judgment or professional medical evaluation.
